This article is an orphan, as no other articles link to it . Please introduce links to this page from related articles ; try the Find link tool for suggestions. (October 2022) |
Rachael Stolzenberg-Solomon | |
|---|---|
| | |
| Alma mater | University of California, Davis Vanderbilt University Johns Hopkins Bloomberg School of Public Health |
| Scientific career | |
| Fields | Metabolic epidemiology, nutrition |
| Institutions | National Cancer Institute |
Rachael Z. Stolzenberg-Solomon is an American epidemiologist and dietitian. She is a senior investigator and head of the metabolic epidemiology branch at the National Cancer Institute.
Stolzenberg-Solomon received a B.S. in nutrition and dietetics at the University of California, Davis, followed by a dietetic internship and M.Ed. in health science (nutrition) education at Vanderbilt University Medical Center and Peabody College, respectively. [1] After this training, she worked as a registered dietitian for ten years. [1] She has an M.P.H. with concentrations in epidemiology and nutrition and a Ph.D., in epidemiology from the Johns Hopkins Bloomberg School of Public Health. [1]
Stolzenberg-Solomon joined the National Cancer Institute (NCI) in 1996 as a predoctoral fellow in the cancer prevention studies branch of the former division of cancer prevention and control and later the center for cancer research and was a cancer prevention fellow in the division of cancer prevention and the division of cancer epidemiology and genetics (DCEG). [1] She became an investigator in DCEG in 2002, and was awarded NIH scientific tenure and promoted to senior investigator in 2011. [1] She heads the metabolic epidemiology branch. [2] Stolzenberg-Solomon has focused much of her research on elucidating the etiology of pancreatic cancer. [1] She has examined dietary, other lifestyle, and genetic factors, including biomarkers related to insulin resistance and metabolomics that may help reveal underlying mechanisms of carcinogenesis. [1] In addition to her work on pancreatic cancer, she has pursued, on a limited basis, other nutrition-related hypotheses including biomarkers in nutritional intervention studies. [1] Stolzenberg-Solomon is a fellow of the American College of Epidemiology and a member of the American Epidemiological Society. [1] [2]
The National Cancer Institute (NCI) coordinates the United States National Cancer Program and is part of the National Institutes of Health (NIH), which is one of eleven agencies that are part of the U.S. Department of Health and Human Services. The NCI conducts and supports research, training, health information dissemination, and other activities related to the causes, prevention, diagnosis, and treatment of cancer; the supportive care of cancer patients and their families; and cancer survivorship.
Joseph W. Cullen was an American cancer prevention and rehabilitation researcher and briefly director of the AMC Cancer Research Center (1989-1990). He previously worked at the VA Hospital in Maryland (1968-1973), the National Institutes of Health (1973), the National Cancer Institute (NCI), and the Jonsson Comprehensive Cancer Center (1976-1982), holding high-level positions such as division director at several. He was a coordinator, creator, and researcher for the Smoking Tobacco and Cancer Program at the NCI, the largest anti-smoking campaign in the world at that time. Cullen wrote more than 90 publications in his lifetime, including four books.
Sheila Rodwell OBE, known professionally by her first married name Sheila Bingham, was a British nutritional epidemiologist known for conducting detailed studies into clarify the biological mechanisms underlying the effects of different diets on health and disease, especially cancer.
Professor Ailsa A. Welch is a professor of nutritional epidemiology at Norwich Medical School in the UK. Her research focuses on the impact of human nutrition on health, disease and aging. She is listed as a notable scientist in Thomson Reuters' Highly Cited Researchers 2014, ranking her among the top 1% most cited scientists.
Gretchen L. Gierach is an American epidemiologist and women's health researcher. She is the Deputy Chief of the Integrative Tumor Epidemiology Branch in the National Cancer Institute.
Louise A. Brinton is an American epidemiologist. She was a senior investigator, Chief of the Hormonal and Reproductive Epidemiology Branch, and the first Scientific Advisor for International Activities of the National Cancer Institute Division of Cancer Epidemiology and Genetics.
Elizabeth "Lisa" Khaykin Cahoon is a Georgian-born American epidemiologist researching cancer and precancer risks conferred by environmental sources of radiation exposure. She is a Stadtman investigator at the National Cancer Institute.

Christine Campo Alewine is an American oncologist and biologist researching immunotoxin therapeutics in pancreatic cancer. She is an investigator at the National Cancer Institute.

Barbara K. Felber is an American biologist specialized in human retrovirus pathogensis and gene regulation. She is a senior investigator in the vaccine branch at the National Cancer Institute.

Rosandra N. Kaplan is an American pediatric oncologist and scientist specialized in translational and clinical research on the mechanisms of cancer spread. She is a principal investigator and head of the tumor microenvironment and metastasis branch at the National Cancer Institute.
Montserrat García-Closas, M.D., M.P.H., Dr.P.H., is a Spanish researcher and academic who is best known for her works on identifying cancer biomarkers and genetic susceptibility to cancer. Dr. García-Closas serves as the deputy director of the Division of Cancer Epidemiology & Genetics (DCEG) of the National Cancer Institute, as well as the Acting Chief of the Integrative Tumor Epidemiology Branch of the DCEG.

Margaret Georgia Kelly was an American pharmacologist specialized in the pharmacology of drugs used in cancer chemotherapy, carcinogenesis, and chemical protection against radiation and alkylating agents. Kelly was a senior investigator in the National Cancer Institute's laboratory of chemical pharmacology.
Xiaohong Rose Yang is an American biomedical scientist researching the genetics of dysplastic nevus syndrome and chordoma, and etiologic heterogeneity of breast cancer. She is a senior investigator at the National Cancer Institute. Yang leads breast cancer studies in mainland China, Hong Kong, and Malaysia.
Martha S. Linet is an American physician epidemiologist. She is a scientist emerita at the National Cancer Institute (NCI). Linet retired in January 2020 after 33 years at NCI. She was a senior investigator and branch chief in the NCI radiation epidemiology branch. Linet specialized in epidemiology, the etiology of pediatric and adult leukemia, lymphoma, and brain tumors, as well as the health effects of ionizing and non-ionizing radiation and benzene exposure.
Elaine Straus Ron was an American epidemiologist specializing in radiation and thyroid cancer. She was a senior investigator in the radiation epidemiology branch at the National Cancer Institute. Ron was an advocate for women in science.
Ruth A. Kleinerman is an American epidemiologist specialized in retinoblastoma. Kleinerman worked at the National Cancer Institute (NCI) from 1979 to 2019 where she served as a staff scientist and deputy chief of the Radiation Epidemiology Branch.
Bríd M. Ryan is an Irish biomedical scientist and cancer researcher. She was an investigator at the National Cancer Institute from 2013 to 2021.
Katrina A. Blouke Goddard is an American genetic epidemiologist and biostatistician specializing in public health genomics and the translation of genomic applications into clinical practice. Goddard is the director of the division of cancer control and population sciences (DCCPS) at the National Cancer Institute (NCI). She was previously the distinguished investigator and director of translational and applied genomics at the Kaiser Permanente Center for Health Research and a faculty member at Case Western Reserve University.
Sharon A. Savage is an American pediatric hematologist/oncologist. She is the clinical director of the National Cancer Institute's Division of Cancer Epidemiology and Genetics.
Jennifer T. Loud is an American nurse practitioner who served as the assistant chief of the National Cancer Institute's clinical genetics branch until August 2020.